O
Organogenesis Holdings Inc (ORGO)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
$0.80
-0.01 (-0.86%)
Market Cap: $105.15M
Last updated: Nov 17, 2026 at 11:06 AM ET
Organogenesis Holdings Inc (ORGO) Valuation Multiples
Organogenesis Holdings (ORGO) trades at 0.3x sales and 0.9x book value. Its P/S of 0.3x is below its 5-year median of 0.9x. Its forward P/E is 12.7x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 12.7x |
| Price to sales | 0.3x |
| Price to book | 0.9x |
| PEG | N/A |
| FCF yield | -0.1% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | N/A | 21.3x | N/A |
| P/S | 0.3x | 0.9x | N/A |
| P/B | 0.9x | 1.6x | N/A |
Valuation History
Over the 6 of the 9 year ends shown that have a P/E, its P/E ranged from 12.7x in 2021 to 57.9x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $5.18 | 17.9x | 1.2x | 1.6x |
| 2024 | $3.20 | 16.3x | 0.9x | 1.1x |
| 2023 | $4.09 | 54.0x | 1.2x | 1.9x |
| 2022 | $2.69 | 15.0x | 0.8x | 1.3x |
| 2021 | $9.24 | 12.7x | 2.6x | 5.1x |
| 2020 | $7.53 | 57.9x | 2.4x | 6.4x |
| 2019 | $4.81 | N/A | 1.7x | 8.5x |
| 2018 | $10.15 | N/A | N/A | 16.6x |
| 2017 | $9.92 | N/A | N/A | N/A |
Frequently Asked Questions About ORGO
What is ORGO's forward P/E ratio?
Organogenesis Holdings has a forward P/E ratio of 12.7x.
What is ORGO's price to sales ratio?
Organogenesis Holdings has a price to sales ratio of 0.3x.
What is Organogenesis Holdings's average P/E ratio over 5 years?
Organogenesis Holdings's median P/E over the last 5 years is 21.3x, from 52 month-end values through Oct 2026.
ORGO pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts